Um die volle Funktionalität der Webseite nutzen zu können, müssen Sie JavaScript in ihrem Browser aktivieren.

DAX24.176,22+0,78 %

Gold3.321,77-0,41 %

Öl (Brent)69,42-0,29 %

Dow Jones44.394,380,00 %

US Tech 10022.714,65+0,13 %

EUR/USD1,17062-0,03 %

Top 15 der gesamten Suchanfragen der letzten 7 Tage

Login

SIGA Technologies Aktie

Aktie

ISIN: US8269171067 WKN: 919473 SYM: SIGA Land Flagge US

USA

Zur Watchlist hinzufügen Zum Portfolio hinzufügen

Zum Portfolio hinzufügen

6,7750

USD

+0,67 %

+0,0450 USD

Letzter Kurs 15:31:02 Nasdaq

SIGA Technologies Aktie kaufen

Geldkurs

15:30:59

6,7600

USD

100 STK

Briefkurs

15:30:59

6,8100

USD

500 STK

BEI SMARTBROKER+ HANDELN

Hinweis
Verlängerte Handelszeiten
Ab sofort von 07:30 bis 23:00 Uhr

Baader Tragding

Neueste Nachrichten

NanoViricides, Inc. Has Filed its Quarterly Report: Broad-Spectrum Antiviral NV-387 To Combat MPox Pandemic in Africa - Phase II Clinical Trial Update, Also Readying to Combat Measles Outbreaks, and to Tackle Bird Flu 16.05.25 · Accesswire · Biocryst Pharmaceuticals
Measles Cases Are Increasing Globally; MPox Continues to Be a Threat - Broad-Spectrum Antiviral Drug Could Be the Solution 14.05.25 · Accesswire · SIGA Technologies
Armis stellt neue globale Technologie-Integrationspartner vor, um die Cyberresilienz von Unternehmen zu stärken 13.05.25 · Business Wire (dt.) · SIGA Technologies
SIGA Reports Financial Results for Three Months Ended March 31, 2025 08.05.25 · globenewswire · SIGA Technologies
Broad-Spectrum Antiviral Drug NV-387 Cleared for Phase II Clinical Trial Application by the National Ethics Committee of the Democratic Republic of Congo 08.05.25 · Accesswire · Gilead Sciences
TCS Corporate Social Responsibility Programs Bring Hope, Connect Communities to the Future of Work 01.05.25 · Accesswire · SIGA Technologies
SIGA to Host Business Update Call on May 8, 2025 Following Release of First-Quarter 2025 Results 01.05.25 · globenewswire · SIGA Technologies
SIGA Declares Special Cash Dividend of $0.60 Per Share 08.04.25 · globenewswire · SIGA Technologies
SIGA Appoints Retired General John M. Keane to its Board of Directors 18.03.25 · globenewswire · SIGA Technologies
SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2024 11.03.25 · globenewswire · SIGA Technologies
SIGA to Host Business Update Call on March 11, 2025 Following Release of Fourth-Quarter and Full Year 2024 Financial Results 04.03.25 · globenewswire · SIGA Technologies
NanoViricides to Present at the MicroCap Conference on Wednesday, January 29, 2025 29.01.25 · Accesswire · SIGA Technologies

1
2
…
3

Meistgelesen

12 Monate

SIGA Announces New Contract Awarded by U.S. Department of Defense for the Procurement of $9 Million ... 628 Leser
Topline Results from PALM 007 Study of SIGA’s Tecovirimat in Treatment of Mpox Released 592 Leser
SIGA Reports Financial Results for Three and Six Months Ended June 30, 2024 416 Leser
SIGA to Host Business Update Call on March 11, 2025 Following Release of Fourth-Quarter and Full ... 224 Leser
SIGA Technologies (SIGA) Shares Tumble After Mpox Therapy Fails, Chief Medical Officer Terminated - ... 212 Leser
SIGA Announces U.S. Government Procurement Order of $113 Million for Oral TPOXX 184 Leser
NanoViricides, Inc. Has Filed Its Quarterly Report: Broad-spectrum Antiviral NV-387 Progressing to ... 180 Leser
SIGA Appoints Retired General John M. Keane to its Board of Directors 144 Leser
SIGA to Host Business Update Call on November 7 Following Release of Third-Quarter 2024 Financial ... 136 Leser
SIGA Announces Agreement to Supply TPOXX in Morocco 136 Leser